HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.

Abstract
TNF-alpha has been implicated as a potentially detrimental cytokine in autoimmune disorders of the nervous system and has been reported to be elevated in antigen-specific therapy of experimental autoimmune neuritis (EAN) in vivo. To investigate the role of TNF-alpha in EAN in rats that had been subjected to antigen-specific therapy with human P2 protein, animals were cotreated with an anti-TNF-alpha neutralizing antibody and the effects of the antibody on disease determined. Using this strategy in adoptive transfer (AT-) EAN, antigen-induced T-cell apoptosis in inflamed sciatic nerve and in liver was reduced to levels observed in control animals indicating that TNF-alpha mediates antigen-induced apoptosis of inflammatory T-cells. Focal liver necrosis, which had been observed in earlier studies after antigen therapy in AT-EAN, was prevented by passive immunization with neutralizing anti-TNF-alpha antibody. Unexpectedly, neutralization of TNF-alpha only partly abolished the protective effect of antigen therapy on the overall disease course. This may indicate that inhibition of TNF-alpha exerts beneficial effects other than through T-cell apoptosis, or that some of the benefit of antigen therapy is mediated by other pathways. These results indicate that secretion of TNF-alpha during antigen therapy has the dual potential to mediate beneficial apoptosis of inflammatory T-cells in the inflammatory lesion and to induce liver damage as a severe side effect.
AuthorsA Weishaupt, R Gold, T Hartung, S Gaupp, A Wendel, W Brück, K V Toyka
JournalJournal of neuropathology and experimental neurology (J Neuropathol Exp Neurol) Vol. 59 Issue 5 Pg. 368-76 (May 2000) ISSN: 0022-3069 [Print] England
PMID10888366 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • Myelin P2 Protein
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
Topics
  • Animals
  • Antigens (administration & dosage, adverse effects, therapeutic use)
  • Apoptosis (drug effects)
  • Cell Line
  • Chemical and Drug Induced Liver Injury
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Liver (pathology, physiopathology)
  • Liver Diseases (prevention & control)
  • Myelin P2 Protein (adverse effects, therapeutic use)
  • Necrosis
  • Neuritis, Autoimmune, Experimental (drug therapy, physiopathology)
  • Rats
  • Rats, Inbred Lew
  • Recombinant Proteins (adverse effects, therapeutic use)
  • Sciatic Nerve (pathology, physiopathology)
  • T-Lymphocytes (metabolism, physiology)
  • Tumor Necrosis Factor-alpha (adverse effects, antagonists & inhibitors, immunology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: